Sustained IL-6/STAT-3 Signaling in Cholangiocarcinoma Cells Due to SOCS-3 Epigenetic Silencing
Open Access
- 1 January 2007
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 132 (1) , 384-396
- https://doi.org/10.1053/j.gastro.2006.10.037
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006
- Helicobacter infection and gastric neoplasiaThe Journal of Pathology, 2005
- Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytesJournal of Hepatology, 2005
- The role of IL-6 and STAT3 in inflammation and cancerEuropean Journal Of Cancer, 2005
- Epigenetic Changes in Solid and Hematopoietic TumorsSeminars in Oncology, 2005
- Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapyHepatology, 2005
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004
- Inflammation and cancerNature, 2002
- Biliary adenocarcinomaJournal of Hepatology, 1985